The global protein stability analysis market is estimated to grow at a CAGR of 8.4% during the forecast period. The major factors encouraging the growth of the market include the significant rise in pharmaceutical R&D programs and the emerging role of bioinformatics software in life science researches. There is an increasing pharmaceutical R&D across countries, such as the US, Europe, and China. For instance, as per the European Federation of Pharmaceutical Industries and Associations (EFPIA), the pharmaceutical R&D was $33.9 billion in 2016, whereas, in 2015, it was $33.4 billion and $27.9 billion in 2010.